By  on January 10, 2019

Brenda Wu, the former SkinCeuticals general manager who went to Derma E as chief executive officer in August, has been appointed ceo of Topix Pharmaceuticals.

Topix acquired Derma E in May 2018, and also owns brands like Replenix, Citrix and Glycolix that are sold through the professional channel. In her new role as head of the parent company, Wu will continue to oversee operations at Derma E.

To continue reading this article...

load comments
blog comments powered by Disqus